Abeona Therapeutics Inc.
ABEO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000318306
In the last 90 days, Abeona Therapeutics Inc. insiders filed 1 open-market purchase and 5 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 17, 2026
- $148.6M
- Insider buysLast 90 days, $34.3K in total
- 1
- Insider sellsLast 90 days, $296.4K in total
- 5
- 13F holdersQ2 2026, +19 vs. previous quarter
- 126
- 13F valueReported value at the end of Q2 2026
- $243.3M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $5.82M
- +37.1% year over year
- Net income, FY2025
- $71.2M
- No comparable prior period
- Free cash flow, FY2025
- -$84.3M
- No comparable prior period
- Revenue, Q3 FY2026
- $13.5M
- No comparable prior period
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net income for FY2025: $71.2M (1223.1% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 16.9M
- Shares sold short
- Change
- −335.0K
- −2.0% vs. previous
- Days to cover
- 21.67
- At average daily volume
Superinvestors holding ABEO, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding ABEO at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Abeona Therapeutics Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 16, 2026 (view filing)8:00 AM ET | Nov 13 | 3 days | Charles Faith L.Director | PPurchase | +15.0K | $2.29 | +$34.3K | +8.5%191.4K after | |
| Sep 29, 2026 (view filing)9:48 PM ET | Sep 29 | Same day | Seshadri VishwasChief Executive Officer | SSale | −19.6K | $5.16 | −$101.1K | −1.5%1.29M after | |
| Sep 29, 2026 (view filing)9:48 PM ET | Sep 29 | Same day | Vazzano Joseph WalterChief Financial Officer | SSale | −9.19K | $5.16 | −$47.4K | −1.9%482.9K after | |
| Sep 29, 2026 (view filing)9:48 PM ET | Sep 29 | Same day | O'Malley Brendan M.SVP, Chief Legal Officer | SSale | −6.73K | $5.16 | −$34.7K | −1.6%421.2K after | |
| Sep 29, 2026 (view filing)9:47 PM ET | Sep 29 | Same day | Vasanthavada MadhavChief Commercial Officer | SSale | −4.90K | $5.16 | −$25.3K | −1.7%285.7K after | |
| Sep 1, 2026 (view filing)5:48 PM ET | Sep 1 | Same day | Alvino MarkDirector | SSale | −15.0K | $5.86 | −$88.0K | −19.5%62.1K after | |
| Jul 22, 2026 (view filing)4:30 PM ET | Jul 21 | 1 day | Vazzano Joseph WalterChief Financial Officer | SSale | −1.48K | $6.53 | −$9.65K | −0.3%492.1K after | |
| Jul 9, 2026 (view filing)7:24 PM ET | Jul 9 | Same day | Vazzano Joseph WalterChief Financial Officer | SSale | −24.9K | $6.96 | −$173.3K | −4.8%493.6K after | |
| Jul 9, 2026 (view filing)7:22 PM ET | Jul 9 | Same day | Seshadri VishwasChief Executive Officer | SSale | −68.0K | $6.96 | −$473.3K | −4.9%1.31M after | |
| Jul 9, 2026 (view filing)7:20 PM ET | Jul 9 | Same day | O'Malley Brendan M.SVP, Chief Legal Officer | SSale | −12.1K | $6.96 | −$83.9K | −2.7%428.0K after |
Top 10 13F holders, Q2 2026
See all 126 holdersThe largest institutional positions in Abeona Therapeutics Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 5,136,490 | $31.7M | 1.92% | +123,438+2.5% | Added |
| BlackRock, Inc. | 3,352,474 | $20.7M | 0.00% | +156,944+4.9% | Added |
| Cable Car Capital LLC | 3,007,329 | $18.6M | 0.40% | 00.0% | Unchanged |
| AIGH Capital Management LLC | 2,987,000 | $18.5M | 1.67% | −113,000−3.6% | Reduced |
| Vanguard Capital Management LLC | 2,211,433 | $13.7M | 0.00% | +46,582+2.2% | Added |
| Resources Investment Advisors, LLC. | 1,653,024 | $10.2M | 0.09% | +1,653,024 | New |
| AWM Investment Company, Inc. | 1,486,130 | $9.18M | 0.80% | +683,000+85.0% | Added |
| Geode Capital Management, LLC | 1,261,090 | $7.80M | 0.00% | +51,293+4.2% | Added |
| Kennedy Capital Management, Inc. | 1,240,071 | $7.66M | 0.14% | −23,440−1.9% | Reduced |
| Goldman Sachs Group Inc | 1,224,806 | $7.57M | 0.00% | +94,187+8.3% | Added |
Holders of 5% or more of ABEO
See all 9 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Abeona Therapeutics Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 13G/A | 9.99%5.78M shares | 0.00 ppfrom 9.99% | Feb 14, 20236 filings | May 15, 2026 | SEC |
| Funicular Funds, LP | 13G/A | 7.50%5.10M shares | +2.20 ppfrom 5.30% | Apr 6, 20262 filings | Nov 13, 2026 | SEC |
| Kaufman Daniel Louis | 13G/A | 7.30%4.16M shares | +2.14 ppfrom 5.16% | Mar 27, 20262 filings | Nov 12, 2026 | SEC |
| TPG GP A, LLC | 13G | 7.00%4.76M shares | New | Nov 16, 20261 filing | Nov 16, 2026 | SEC |
| James Russell Revocable Trust | 13D | 6.10%3.48M shares | +0.80 ppfrom 5.30% | Sep 30, 20252 filings | Oct 23, 2026 | SEC |